Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
Is it possible to prevent atrophy of key brain regions related to cognitive decline and Alzheimer’s disease (AD)? One approach is to modify nongenetic risk factors, for instance by lowering elevated plasma homocysteine using B vitamins. In an initial, randomized controlled study on elderly subjects...
Main Authors: | Douaud, G, Refsum, H, De Jager, C, Jacoby, R, Nichols, T, Smith, S, Smith, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
National Academy of Sciences
2013
|
Similar Items
-
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
by: Douaud, G, et al.
Published: (2013) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
by: Smith, A, et al.
Published: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012)